The global market of Vitamin B* (Folic Acid) has demonstrated a firm and measured price performance through June **** and maintained a stable upward trajectory across major international and domestic markets. A combination of strategic supply-side management by exporters and consistent downstream procurement from pharmaceutical, nutraceutical and wellness sectors have ensured that the market remained resilient despite varying regional demand dynamics. The suppliers of Vitamin B* in key export hubs in China and the USA have maintained controlled inventory release strategies while buyers in Europe, India and other import-dependent regions have aligned their procurement schedules with ongoing production cycles and seasonal demand expectations.
The steady sentiment of Vitamin B* prices was driven by sustained demand from pharmaceutical manufacturers formulating prenatal health supplements, immunity-enhancing therapies and folic acid-fortified nutraceutical blends. The personal care product makers in India and Southeast Asia have increased...
Leave a Comment
Comments (0)